{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"srd5a3-congenital-disorder-of-glycosylation","columns":[{"gene":"","key":"population-717d8a2c54b978e66630","label":"Congenital disorder of glycosylation, type IQ","mondoId":"MONDO:0012885","onsetQualifier":null,"originColumnKey":"MONDO:0012885/OMIM:612379","originalViews":[{"key":"MONDO:0012885/OMIM:612379","label":"Congenital disorder of glycosylation, type IQ","scopeLabel":"OMIM:612379","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["04c17689fdaba7d3d5adc5dcc6830159395fec87ca33828c87a2f5ee1eecc0c6","097d5315ec21b81a445aef2c76720a8e96f11ee65e94b79dafbb084e4a4b27bc","18d7f7abafcade653fce0c231685db52ef830582ecf84c3973d2d81df85cd6c4","22d8424dca44ff28ee805597150fe5bf7556b6ba7536c27197f0f9d987c9c384","2c89f53d95864f593ccceeb96bef3334c2a01d12b28e2a5f62ef4e8d7e0ab69a","3208707e331158e1f5f82c7dc10ebd48f489ee31a8612e15100673305493bf83","365f26a49f3f494af0cd90b5e76792160076d3b6a6ff4e7f643838edb75d5134","37a792c18e7a175fcc88f47656edc1091a638a2c991db9e44cdd6adefa437106","3a8c3305e5b51edd9da0474dd859fc0d31ade383478a37b114efac59543bab03","3e906f269f5abb5b60ca4b00da780293a8cecd42ab2556effac7948c9fcbe99e","515b3a687e3eb189b70947cea064f9e49be8e9063cc72919a7924d25cddefe98","592c537e4dec5b23cc3458981829b024eb767819a8e502a74c432382f2266e90","5abeb560ebbee1a542a2910fc186ae1e67666b4c14a167cf4bad68b46f51aefa","6e849573ee89da905482b58d4f5d3cac5564fe49d8117ff5056845981b0a67a4","7dcb418b4b334f68245941c4994a80a36a25dc72586216ad5ff7fbd803439e27","7ed184ff7af704b149a28f2747986ef65493551295b3d3a56ee0f4416fc50e49","879b906775dca45b52d9bba5fddea3e0ec4b90978aa7ba56b90de1bf8b9134a0","89a0c99b97c8d23418705c8353fbc65a123ebc1850d9298f3f8ea783b6b26ad9","8cb67a2584ffe3392537d75bdb63b62201c07fe7b81f8e2df62c2e63d6505dd7","8f097096db655138bff0d2673c56d51156e2df05c26278634029655ea86008a5","b16435586328c2002fa8667f0f1bc13981e4238b77491bc4b56f1c63aec58d73","c5ebaa32521bb9f87c9e79fb1d5b6a732f237ba274dc9406ea5c78d551629b39","cd3d778392769573c6092b7557d7ac96d3a9d7adc3250009907d9b6216b16869","cfd8ab7a59479af78464c8e5787c3626efc9a21072eacee4a9b916f37d012523","dd8e3fec4e66d1b9fa161175e8821c855841fe0ef5b649f1a49c7bba578b7a55","e01f69bf1892377801f6ac83825129b6c6283981faeb725c6bb68acf8e216ebe","e029e18de647ca22078459c624d42e56db34ff1d0843b371fc644b6327a6921e","e2500718933451fc4ebc1aafda79bf89d7b541886a9b2601b2cf9b67dca9586d","e68ae5fc82eea5d9e8daaee3500e7dbe2fb2baf06ead66623554bc658cd58b44","ea46481bfec3b3d094f276ee0ce98a7bc617edffb9a4421ecba4697931181843","ed2a30c8392859f6adbf51ddad19f7d03af0dd082fcf225a397118e5e7456c31"],"recordQualifiers":{},"scopeLabel":"OMIM:612379","sourceIds":["OMIM:612379"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-2a8b563558db6d137de6","label":"SRD5A3-CDG","mondoId":"MONDO:0012885","onsetQualifier":null,"originColumnKey":"MONDO:0012885/ORPHA:324737","originalViews":[{"key":"MONDO:0012885/ORPHA:324737","label":"SRD5A3-CDG","scopeLabel":"ORPHA:324737","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["00b8a5dae0c66b1a8e530adcc25cb1aba99ccd8b9b7af045ce37f07f3a976493","03d736f5c48751bee514414a05c161540cfde12e69ebe95205e6bde4ac822fb0","0759bf3bd0eab723aa7165fc1c4d6e19a922f70ca6ba9b6a587e1414a24ee5b2","0b28ce7d8e9ca388150796c22f958bb8284a868ade9202c8c66a372cb1037b4f","0edd76e1433a7dbc30454042869d2fe299771ef519276f0ea7dd657f76d71f93","1bbdc1b1938ddddf4111c9c2e62c77ffcf08ceaa4eaed8d353b138b7a0ce2e0b","1e374436197612d1e7ed025c2407ea8904b628d4ad9f63b1133eb2a5b7df8af3","27eabe9ced0b5597d70532f0a546671acc974d63dc2252059d7e0b0604c74c4c","2ab7f654f4ad2eca65380fc88b95295e4e73e97c0bf8f846d137a14a7d620054","31f9d81698ae342687fdcecd665640f4bd942ef464e4dcfeaf60f3b6fbad701a","36487b04e2895f533d97ea2c8d356a7e84e8f5c17023e363f51ad4475f262609","3d39dad013696028188e48291e07b45b977f85d8a5fe28fd0b27853bce6364c6","49f1e2705d1aed39ead0da46818393da6dbe2b49c8387234520aafa8439f53ce","65b9c038bd950bd89eae3e1ba13a1ed544ae616bbf48193cee3567e12894a8ea","6def31976c7d12b78575d735e350c8bf4659f662b02a9d2d159f57f33883d21d","7da7fb238ea970fbfe24a1ff1830323bbab7c4b482257cd14173a69b7c50119b","8939c8d143f8abd301a3c6259b4888195b27a00f2b33163462d7a1742b022558","8d08a55cfd9cfe69d5ceaba5b9584852b5e660c67bf69d1d5bd14c82fb8a095a","990261e507ccc91882a9e5499bf4713c1b37790771813b1ad16bebdbfc27dd86","a40072201d6a41954634c5f70cdc0463c92a4c87a96c213cd836222156700c1e","ab9dc2ac8c80f5a9671bd76a86c10298572de3822556a2030dbd7d20bf3a867b","b3135ec1b4c6937389e562f45d7fb4c9e58b7f95d4ddc1fd1bac89bbdccdadd2","b49b4a8497ce387c4b9b7ce55be14c07d23db88a16a899f2a40ee0259f9bc024","c8314021c5f1db0acb4e1105fcd26c8539b486b6d94d6acb2fb45683684341c3","cb2072de845e4d8ea599d1a1e519f7a2d3db8e7282a98d6b1181496cf0e7e9de","cec526cf8397c0f64294d4d73f2690fac3b2b34571d95cb7a8c4c2ad2757c642","d237daf53c01e3b7d7732bb3bc56d773f0aaedfbc397190939f6fbcc6a3d9464","d7644e5e593212a6036c810d9da3e8c55a31f33925497a2f162bedae9b8b373a","d8a66ebe05b39d7908c0cbed8078b1dc97e8e2fa8e01f7e153e4a828d65ee66f","dbb175f198b6b571600fc575d7161d5e3eca0062cc7796f8fab40ed6919d8544","ddea0f2be76fd71faacaa07c620df17eebb565b984e766631e397333816abe9c","e7091f0e355ab4e7a5a679e67b8e50b471e69dec788140abac7fb487552a9047","f446a3bfcbf93f0e07ed431359c385bbc3d5a0228aea0d07dd24effaf7c12123"],"recordQualifiers":{},"scopeLabel":"ORPHA:324737","sourceIds":["ORPHA:324737"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-717d8a2c54b978e66630","population-2a8b563558db6d137de6"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012443","HP:0030680","HP:0002334","HP:0001317","HP:0001999","HP:0001595","HP:0005107"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":20,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":64,"sourceGroups":{"omim":9,"orphanet":33,"published":22}},"features":[{"hpoId":"HP:0012443","label":"Abnormal brain morphology","primary":true},{"hpoId":"HP:0030680","label":"Abnormal cardiovascular system morphology","primary":true},{"hpoId":"HP:0002334","label":"Abnormal cerebellar vermis morphology","primary":true},{"hpoId":"HP:0001317","label":"Abnormal cerebellum morphology","primary":true},{"hpoId":"HP:0001999","label":"Abnormal facial shape","primary":true},{"hpoId":"HP:0001595","label":"Abnormal hair morphology","primary":true},{"hpoId":"HP:0005107","label":"Abnormal sacrum morphology","primary":true},{"hpoId":"HP:0001000","label":"Abnormal skin pigmentation","primary":false},{"hpoId":"HP:0001928","label":"Abnormality of coagulation","primary":false},{"hpoId":"HP:0001251","label":"Ataxia","primary":false},{"hpoId":"HP:0000248","label":"Brachycephaly","primary":false},{"hpoId":"HP:0000518","label":"Cataract","primary":false},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":false},{"hpoId":"HP:0001320","label":"Cerebellar vermis hypoplasia","primary":false},{"hpoId":"HP:0000589","label":"Coloboma","primary":false},{"hpoId":"HP:0000973","label":"Cutis laxa","primary":false},{"hpoId":"HP:0000824","label":"Decreased response to growth hormone stimulation test","primary":false},{"hpoId":"HP:0005280","label":"Depressed nasal bridge","primary":false},{"hpoId":"HP:0000958","label":"Dry skin","primary":false},{"hpoId":"HP:0002015","label":"Dysphagia","primary":false},{"hpoId":"HP:0000964","label":"Eczematoid dermatitis","primary":false},{"hpoId":"HP:0002910","label":"Elevated circulating hepatic transaminase concentration","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0008947","label":"Floppy infant","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":false},{"hpoId":"HP:0000962","label":"Hyperkeratosis","primary":false},{"hpoId":"HP:0000316","label":"Hypertelorism","primary":false},{"hpoId":"HP:0000998","label":"Hypertrichosis","primary":false},{"hpoId":"HP:0000821","label":"Hypothyroidism","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0008064","label":"Ichthyosis","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0003186","label":"Inverted nipples","primary":false},{"hpoId":"HP:0002808","label":"Kyphosis","primary":false},{"hpoId":"HP:0000369","label":"Low-set ears","primary":false},{"hpoId":"HP:0001935","label":"Microcytic anemia","primary":false},{"hpoId":"HP:0000568","label":"Microphthalmia","primary":false},{"hpoId":"HP:0001270","label":"Motor delay","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000677","label":"Oligodontia","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0007766","label":"Optic disc hypoplasia","primary":false},{"hpoId":"HP:0000982","label":"Palmoplantar keratoderma","primary":false},{"hpoId":"HP:0002126","label":"Polymicrogyria","primary":false},{"hpoId":"HP:0001976","label":"Reduced antithrombin III activity","primary":false},{"hpoId":"HP:0000510","label":"Rod-cone dystrophy","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0005585","label":"Spotty hyperpigmentation","primary":false},{"hpoId":"HP:0003642","label":"Type I transferrin isoform profile","primary":false},{"hpoId":"HP:0000572","label":"Visual loss","primary":false}],"ledeHtml":"SRD5A3-congenital disorder of glycosylation (SRD5A3-CDG, formerly known as congenital disorder of glycosylation type Iq) is an inherited condition that causes neurological and vision problems and other signs and symptoms. The pattern and severity of this condition&#x27;s features vary widely among affected individuals. Individuals with SRD5A3-CDG typically develop signs and symptoms of the condition during infancy or early childhood. Most individuals with SRD5A3-CDG have intellectual disability, vision problems, unusual facial features, low muscle tone (hypotonia), and problems with coordination and balance (ataxia). Vision problems in SRD5A3-CDG often include involuntary side-side movements of the eyes (nystagmus), a gap or hole in one of the structures of the eye (coloboma), underdevelopment of the nerves that carry signals between the eyes and the brain (optic nerve hypoplasia), or vision loss early in life (early-onset severe retinal dystrophy). Over time, affected individuals may develop clouding of the lenses of the eyes (cataracts) or increased pressure in the eyes (glaucoma). Other features of SRD5A3-CDG can include skin rash, unusually small red blood cells (microcytic anemia), and liver problems.","mondoId":"MONDO:0012885","node":{"canonicalSlug":"srd5a3-congenital-disorder-of-glycosylation","comparisons":[{"documentSha256":"93ed48c975cf21ed36c0202fb082491f55572bd2cab3d57e1cc9857282d7c5f4","key":"legacy-srd5a3-congenital-disorder-of-glycosylation","kind":"legacy","label":"SRD5A3-congenital disorder of glycosylation","memberIds":["MONDO:0012885"],"mondoId":"MONDO:0012885","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/srd5a3-congenital-disorder-of-glycosylation.93ed48c975cf21ed36c0202fb082491f55572bd2cab3d57e1cc9857282d7c5f4.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"SRD5A3-congenital disorder of glycosylation","originalSourceId":"ORPHA:324737","paragraphs":["SRD5A3-congenital disorder of glycosylation (SRD5A3-CDG, formerly known as congenital disorder of glycosylation type Iq) is an inherited condition that causes neurological and vision problems and other signs and symptoms. The pattern and severity of this condition's features vary widely among affected individuals. Individuals with SRD5A3-CDG typically develop signs and symptoms of the condition during infancy or early childhood. Most individuals with SRD5A3-CDG have intellectual disability, vision problems, unusual facial features, low muscle tone (hypotonia), and problems with coordination and balance (ataxia). Vision problems in SRD5A3-CDG often include involuntary side-side movements of the eyes (nystagmus), a gap or hole in one of the structures of the eye (coloboma), underdevelopment of the nerves that carry signals between the eyes and the brain (optic nerve hypoplasia), or vision loss early in life (early-onset severe retinal dystrophy). Over time, affected individuals may develop clouding of the lenses of the eyes (cataracts) or increased pressure in the eyes (glaucoma). Other features of SRD5A3-CDG can include skin rash, unusually small red blood cells (microcytic anemia), and liver problems."],"rawAttribution":"MONDO:0012885","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T16:59:49Z","upstream":"MONDO:0012885","url":"https://rarediseases.info.nih.gov/diseases/12397"},"ownColumnKeys":["population-717d8a2c54b978e66630","population-2a8b563558db6d137de6"],"publication":"published","relationships":[{"kind":"parent","label":"congenital disorder of glycosylation type I","mondoId":"MONDO:0005500","slug":"congenital-disorder-of-glycosylation-type-i"},{"kind":"parent","label":"disorder of multiple glycosylation","mondoId":"MONDO:0017749","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"00b8a5dae0c66b1a8e530adcc25cb1aba99ccd8b9b7af045ce37f07f3a976493","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000677","is_excluded":true,"label":"Oligodontia","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"03d736f5c48751bee514414a05c161540cfde12e69ebe95205e6bde4ac822fb0","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007766","is_excluded":false,"label":"Optic disc hypoplasia","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"04c17689fdaba7d3d5adc5dcc6830159395fec87ca33828c87a2f5ee1eecc0c6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002126","is_excluded":false,"label":"Polymicrogyria","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"0759bf3bd0eab723aa7165fc1c4d6e19a922f70ca6ba9b6a587e1414a24ee5b2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"097d5315ec21b81a445aef2c76720a8e96f11ee65e94b79dafbb084e4a4b27bc","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0000958","is_excluded":false,"label":"Dry skin","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0b28ce7d8e9ca388150796c22f958bb8284a868ade9202c8c66a372cb1037b4f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0edd76e1433a7dbc30454042869d2fe299771ef519276f0ea7dd657f76d71f93","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008064","is_excluded":false,"label":"Ichthyosis","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"18d7f7abafcade653fce0c231685db52ef830582ecf84c3973d2d81df85cd6c4","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1bbdc1b1938ddddf4111c9c2e62c77ffcf08ceaa4eaed8d353b138b7a0ce2e0b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000510","is_excluded":false,"label":"Rod-cone dystrophy","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1e374436197612d1e7ed025c2407ea8904b628d4ad9f63b1133eb2a5b7df8af3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012443","is_excluded":false,"label":"Abnormal brain morphology","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"22d8424dca44ff28ee805597150fe5bf7556b6ba7536c27197f0f9d987c9c384","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"4/7","hpo_id":"HP:0008064","is_excluded":false,"label":"Ichthyosis","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"27eabe9ced0b5597d70532f0a546671acc974d63dc2252059d7e0b0604c74c4c","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000365","is_excluded":true,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2ab7f654f4ad2eca65380fc88b95295e4e73e97c0bf8f846d137a14a7d620054","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002808","is_excluded":false,"label":"Kyphosis","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2c89f53d95864f593ccceeb96bef3334c2a01d12b28e2a5f62ef4e8d7e0ab69a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"31f9d81698ae342687fdcecd665640f4bd942ef464e4dcfeaf60f3b6fbad701a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3208707e331158e1f5f82c7dc10ebd48f489ee31a8612e15100673305493bf83","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000973","is_excluded":false,"label":"Cutis laxa","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"36487b04e2895f533d97ea2c8d356a7e84e8f5c17023e363f51ad4475f262609","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001999","is_excluded":false,"label":"Abnormal facial shape","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"365f26a49f3f494af0cd90b5e76792160076d3b6a6ff4e7f643838edb75d5134","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0000964","is_excluded":false,"label":"Eczematoid dermatitis","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"37a792c18e7a175fcc88f47656edc1091a638a2c991db9e44cdd6adefa437106","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3a8c3305e5b51edd9da0474dd859fc0d31ade383478a37b114efac59543bab03","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3d39dad013696028188e48291e07b45b977f85d8a5fe28fd0b27853bce6364c6","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3e906f269f5abb5b60ca4b00da780293a8cecd42ab2556effac7948c9fcbe99e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"49f1e2705d1aed39ead0da46818393da6dbe2b49c8387234520aafa8439f53ce","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"515b3a687e3eb189b70947cea064f9e49be8e9063cc72919a7924d25cddefe98","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000316","is_excluded":false,"label":"Hypertelorism","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"592c537e4dec5b23cc3458981829b024eb767819a8e502a74c432382f2266e90","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001000","is_excluded":false,"label":"Abnormal skin pigmentation","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"5abeb560ebbee1a542a2910fc186ae1e67666b4c14a167cf4bad68b46f51aefa","raw":{"aspect":"P","body_system":"breast","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0003186","is_excluded":false,"label":"Inverted nipples","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"65b9c038bd950bd89eae3e1ba13a1ed544ae616bbf48193cee3567e12894a8ea","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001935","is_excluded":false,"label":"Microcytic anemia","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6def31976c7d12b78575d735e350c8bf4659f662b02a9d2d159f57f33883d21d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005107","is_excluded":false,"label":"Abnormal sacrum morphology","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"6e849573ee89da905482b58d4f5d3cac5564fe49d8117ff5056845981b0a67a4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7da7fb238ea970fbfe24a1ff1830323bbab7c4b482257cd14173a69b7c50119b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000589","is_excluded":false,"label":"Coloboma","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"7dcb418b4b334f68245941c4994a80a36a25dc72586216ad5ff7fbd803439e27","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7ed184ff7af704b149a28f2747986ef65493551295b3d3a56ee0f4416fc50e49","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0000568","is_excluded":false,"label":"Microphthalmia","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"879b906775dca45b52d9bba5fddea3e0ec4b90978aa7ba56b90de1bf8b9134a0","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000962","is_excluded":false,"label":"Hyperkeratosis","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"8939c8d143f8abd301a3c6259b4888195b27a00f2b33163462d7a1742b022558","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"89a0c99b97c8d23418705c8353fbc65a123ebc1850d9298f3f8ea783b6b26ad9","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001976","is_excluded":false,"label":"Reduced antithrombin III activity","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8cb67a2584ffe3392537d75bdb63b62201c07fe7b81f8e2df62c2e63d6505dd7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003642","is_excluded":false,"label":"Type I transferrin isoform profile","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"8d08a55cfd9cfe69d5ceaba5b9584852b5e660c67bf69d1d5bd14c82fb8a095a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030680","is_excluded":false,"label":"Abnormal cardiovascular system morphology","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"8f097096db655138bff0d2673c56d51156e2df05c26278634029655ea86008a5","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0000589","is_excluded":false,"label":"Coloboma","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"990261e507ccc91882a9e5499bf4713c1b37790771813b1ad16bebdbfc27dd86","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a40072201d6a41954634c5f70cdc0463c92a4c87a96c213cd836222156700c1e","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ab9dc2ac8c80f5a9671bd76a86c10298572de3822556a2030dbd7d20bf3a867b","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001928","is_excluded":false,"label":"Abnormality of coagulation","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b16435586328c2002fa8667f0f1bc13981e4238b77491bc4b56f1c63aec58d73","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0002910","is_excluded":false,"label":"Elevated circulating hepatic transaminase concentration","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b3135ec1b4c6937389e562f45d7fb4c9e58b7f95d4ddc1fd1bac89bbdccdadd2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003642","is_excluded":false,"label":"Type I transferrin isoform profile","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b49b4a8497ce387c4b9b7ce55be14c07d23db88a16a899f2a40ee0259f9bc024","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000572","is_excluded":false,"label":"Visual loss","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c5ebaa32521bb9f87c9e79fb1d5b6a732f237ba274dc9406ea5c78d551629b39","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000369","is_excluded":false,"label":"Low-set ears","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c8314021c5f1db0acb4e1105fcd26c8539b486b6d94d6acb2fb45683684341c3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb2072de845e4d8ea599d1a1e519f7a2d3db8e7282a98d6b1181496cf0e7e9de","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002334","is_excluded":false,"label":"Abnormal cerebellar vermis morphology","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"cd3d778392769573c6092b7557d7ac96d3a9d7adc3250009907d9b6216b16869","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0000572","is_excluded":false,"label":"Visual loss","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"cec526cf8397c0f64294d4d73f2690fac3b2b34571d95cb7a8c4c2ad2757c642","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001595","is_excluded":true,"label":"Abnormal hair morphology","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"cfd8ab7a59479af78464c8e5787c3626efc9a21072eacee4a9b916f37d012523","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000998","is_excluded":false,"label":"Hypertrichosis","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d237daf53c01e3b7d7732bb3bc56d773f0aaedfbc397190939f6fbcc6a3d9464","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008947","is_excluded":false,"label":"Floppy infant","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d7644e5e593212a6036c810d9da3e8c55a31f33925497a2f162bedae9b8b373a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000982","is_excluded":false,"label":"Palmoplantar keratoderma","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d8a66ebe05b39d7908c0cbed8078b1dc97e8e2fa8e01f7e153e4a828d65ee66f","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000824","is_excluded":false,"label":"Decreased response to growth hormone stimulation test","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dbb175f198b6b571600fc575d7161d5e3eca0062cc7796f8fab40ed6919d8544","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001317","is_excluded":false,"label":"Abnormal cerebellum morphology","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"dd8e3fec4e66d1b9fa161175e8821c855841fe0ef5b649f1a49c7bba578b7a55","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"5/7","hpo_id":"HP:0001935","is_excluded":false,"label":"Microcytic anemia","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ddea0f2be76fd71faacaa07c620df17eebb565b984e766631e397333816abe9c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000821","is_excluded":false,"label":"Hypothyroidism","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e01f69bf1892377801f6ac83825129b6c6283981faeb725c6bb68acf8e216ebe","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001320","is_excluded":false,"label":"Cerebellar vermis hypoplasia","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e029e18de647ca22078459c624d42e56db34ff1d0843b371fc644b6327a6921e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e2500718933451fc4ebc1aafda79bf89d7b541886a9b2601b2cf9b67dca9586d","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000248","is_excluded":false,"label":"Brachycephaly","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e68ae5fc82eea5d9e8daaee3500e7dbe2fb2baf06ead66623554bc658cd58b44","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e7091f0e355ab4e7a5a679e67b8e50b471e69dec788140abac7fb487552a9047","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005585","is_excluded":false,"label":"Spotty hyperpigmentation","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ea46481bfec3b3d094f276ee0ce98a7bc617edffb9a4421ecba4697931181843","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0005280","is_excluded":false,"label":"Depressed nasal bridge","onset_id":null,"reference":"OMIM:612379","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"ed2a30c8392859f6adbf51ddad19f7d03af0dd082fcf225a397118e5e7456c31","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612379","disease_name":"Congenital disorder of glycosylation, type IQ","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:20637498","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f446a3bfcbf93f0e07ed431359c385bbc3d5a0228aea0d07dd24effaf7c12123","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:324737","disease_name":"SRD5A3-CDG","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001976","is_excluded":false,"label":"Reduced antithrombin III activity","onset_id":null,"reference":"ORPHA:324737","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12397\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012885\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0012885</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>SRD5A3-congenital disorder of glycosylation (SRD5A3-CDG, formerly known as congenital disorder of glycosylation type Iq) is an inherited condition that causes neurological and vision problems and other signs and symptoms. The pattern and severity of this condition&#x27;s features vary widely among affected individuals. Individuals with SRD5A3-CDG typically develop signs and symptoms of the condition during infancy or early childhood. Most individuals with SRD5A3-CDG have intellectual disability, vision problems, unusual facial features, low muscle tone (hypotonia), and problems with coordination and balance (ataxia). Vision problems in SRD5A3-CDG often include involuntary side-side movements of the eyes (nystagmus), a gap or hole in one of the structures of the eye (coloboma), underdevelopment of the nerves that carry signals between the eyes and the brain (optic nerve hypoplasia), or vision loss early in life (early-onset severe retinal dystrophy). Over time, affected individuals may develop clouding of the lenses of the eyes (cataracts) or increased pressure in the eyes (glaucoma). Other features of SRD5A3-CDG can include skin rash, unusually small red blood cells (microcytic anemia), and liver problems.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12397\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"srd5a3-congenital-disorder-of-glycosylation","sourceDocuments":[{"name":"GARD: SRD5A3-congenital disorder of glycosylation","reviewed":null,"source_release":"2026-10-21T16:59:49Z","url":"https://rarediseases.info.nih.gov/diseases/12397"},{"name":"MONDO: SRD5A3-congenital disorder of glycosylation","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012885"}],"sourceNote":"","synonyms":["CDG syndrome type Iq","CDG-Iq","CDG1Q","CDGIq","congenital disorder of glycosylation due to steroid 5alpha-reductase type 3 deficiency","congenital disorder of glycosylation type 1q","congenital disorder of glycosylation type Iq","congenital disorder of glycosylation, type Iq","SRD5A3-CDG","SRD5A3-CDG (CDG-Iq)","SRD5A3-congenital disorder of glycosylation","SRD5A3-related congenital disorder of glycosylation"],"takeawayHtml":"","title":"SRD5A3-congenital disorder of glycosylation"},"schemaVersion":1}
